Your browser doesn't support javascript.
loading
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Zola Matuvanga, Trésor; Larivière, Ynke; Lemey, Gwen; De Bie, Jessie; Milolo, Solange; Meta, Rachel; Esanga, Emmanuel; Vermeiren, Paul Peter; Thys, Séverine; Van Geertruyden, Jean-Pierre; Van Damme, Pierre; Maketa, Vivi; Matangila, Junior; Mitashi, Patrick; Muhindo-Mavoko, Hypolite.
Afiliación
  • Zola Matuvanga T; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Hea
  • Larivière Y; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium. Electronic address: ynke.lariviere@uantwerpen.be.
  • Lemey G; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.
  • De Bie J; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.
  • Milolo S; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo.
  • Meta R; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo.
  • Esanga E; Tshuapa Provincial Health Division, The Democratic Republic of the Congo.
  • Vermeiren PP; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.
  • Thys S; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.
  • Van Geertruyden JP; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.
  • Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
  • Maketa V; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo.
  • Matangila J; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo.
  • Mitashi P; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo.
  • Muhindo-Mavoko H; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo.
Vaccine ; 40(25): 3470-3480, 2022 05 31.
Article en En | MEDLINE | ID: mdl-35550847

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola / Ebolavirus Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola / Ebolavirus Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos